Venmax Drugs & Pharmaceuticals submits unaudited standalone financial results

23 Jul 2025 Evaluate

Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Venmax Drugs & Pharmaceuticals has informed that it enclosed the Un-audited Standalone Financial Results along with Limited Review Report of the Statutory Auditors of the company, PPKG & Co Chartered Accountants for the quarter ended 30th June, 2025. The Financial Results are also available on the website of the Company at www.venmaxdrugs.com and on the website of BSE www.bseindia.com. The Board Meeting commenced at 02:00 pm and concluded at 03:20 pm.

The above information is a part of company’s filings submitted to BSE. 


Venmax Drugs&Pharma Share Price

26.55 0.62 (2.39%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×